Literature DB >> 4365570

Regulation of melanocyte stimulating hormone action at the receptor level: discontinuous binding of hormone to synchronized mouse melanoma cells during the cell cycle.

J M Varga, A Dipasquale, J Pawelek, J S McGuire, A B Lerner.   

Abstract

Melanocyte stimulating hormone coupled to Sepharose effects an increase in tryosinase (EC 1.14.18.1; monophenol monoxygenase) activity of cultivated mouse melanoma cells. Synchronized cells are found to respond to melanocyte stimulating hormone only in the G2 phase of the cell cycle, although their response to cyclic AMP is independent of position in the cell cycle. The binding of (125)I-labeled melanocyte stimulating hormone occurs predominantly in G2. These observations are satisfied by a model in which the hormone can activate adenylate cyclase (EC 4.6.1.1) by binding to a melanocyte stimulating hormone receptor only in G2; the events distal to cyclic AMP production can occur throughout the cell cycle.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4365570      PMCID: PMC388281          DOI: 10.1073/pnas.71.5.1590

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  12 in total

1.  Preparation of iodine-131 labelled human growth hormone of high specific activity.

Authors:  W M HUNTER; F C GREENWOOD
Journal:  Nature       Date:  1962-05-05       Impact factor: 49.962

2.  Control of phenotypic expression of cultured melanoma cells by melanocyte stimulating hormones.

Authors:  G Wong; J Pawelek
Journal:  Nat New Biol       Date:  1973-02-14

3.  Cyclic adenosine 3',5'-monophosphate in the control of melanoma cell replication and differentiation.

Authors:  J W Kreider; M Rosenthal; N Lengle
Journal:  J Natl Cancer Inst       Date:  1973-02       Impact factor: 13.506

4.  A difference in the architecture of the surface membrane of normal and virally transformed cells.

Authors:  M M Burger
Journal:  Proc Natl Acad Sci U S A       Date:  1969-03       Impact factor: 11.205

5.  Effects of cyclic adenosine monophosphate and melanocyte-stimulating hormone on frog skin in vitro.

Authors:  M W Bitensky; S R Burstein
Journal:  Nature       Date:  1965-12-25       Impact factor: 49.962

6.  Inactivation of calcitonin by specific organs.

Authors:  F R Singer; J F Habener; E Greene; P Godin; J T Potts
Journal:  Nat New Biol       Date:  1972-06-28

7.  Purification and properties of HeLa cell plasma membranes.

Authors:  P H Atkinson; D F Summers
Journal:  J Biol Chem       Date:  1971-08-25       Impact factor: 5.157

Review 8.  The biochemistry of melanotropic agents.

Authors:  S Lande; A B Lerner
Journal:  Pharmacol Rev       Date:  1967-03       Impact factor: 25.468

9.  Adenosine 3',5'-monophosphate (cyclic AMP) as the mediator of the actions of melanocyte stimulating hormone (MSH) and norepinephrine on the frog skin.

Authors:  K Abe; R W Butcher; W E Nicholson; C E Baird; R A Liddle; G W Liddle
Journal:  Endocrinology       Date:  1969-02       Impact factor: 4.736

10.  Molecular biology of pigment cells. Molecular controls in mammalian pigmentation.

Authors:  J Pawelek; G Wong; M Sansone; J Morowitz
Journal:  Yale J Biol Med       Date:  1973-12
View more
  22 in total

1.  Induction of erythroid differentiation by dimethylsulfoxide in cells infected with Friend virus: relationship to the cell cycle.

Authors:  J Levy; M Terada; R A Rifkind; P A Marks
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

2.  Association of cell surface receptors for melanotropin with the Golgi region in mouse melanoma cells.

Authors:  J M Varga; G Moellmann; P Fritsch; E Godawska; A B Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1976-02       Impact factor: 11.205

3.  Melanoma cells resistant to inhibition of growth by melanocyte stimulating hormone.

Authors:  J Pawelek; M Sansone; N Koch; G Christie; R Halaban; J Hendee; A B Lerner; J M Varga
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205

Review 4.  Immunoconjugates: applications in targeted drug delivery for cancer therapy.

Authors:  B P Ram; P Tyle
Journal:  Pharm Res       Date:  1987-06       Impact factor: 4.200

5.  Membrane receptors for hormones and neurotransmitters.

Authors:  C R Kahn
Journal:  J Cell Biol       Date:  1976-08       Impact factor: 10.539

6.  Long-term and residual melanotropin-stimulated tyrosinase activity in S91 melanoma cells is density dependent.

Authors:  Z A Abdel Malek; K L Kreutzfeld; M E Hadley; M D Bregman; V J Hruby; F L Meyskens
Journal:  In Vitro Cell Dev Biol       Date:  1986-02

7.  DNA damage enhances melanogenesis.

Authors:  M S Eller; K Ostrom; B A Gilchrest
Journal:  Proc Natl Acad Sci U S A       Date:  1996-02-06       Impact factor: 11.205

8.  Combinatorial diffusion assay used to identify topically active melanocyte-stimulating hormone receptor antagonists.

Authors:  J M Quillan; C K Jayawickreme; M R Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

9.  Melanotropin receptors demonstrated in situ in human melanoma.

Authors:  J B Tatro; M Atkins; J W Mier; S Hardarson; H Wolfe; T Smith; M L Entwistle; S Reichlin
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

10.  The number of receptors for beta-melanocyte stimulating hormone in Cloudman melanoma cells is increased by dibutyryl adenosine 3':5'-cyclic monophosphate or cholera toxin.

Authors:  A DiPasquale; J McGuire; J M Varga
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.